Lofaro LR - Search Results

1

Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.

Raval AA, Benn BS, Benzaquen S, Maouelainin N, Johnson M, Huang J, Lofaro LR, Ansari A, Geurink C, Kennedy GC, Bulman WA, Kurman JS. Raval AA, et al. Among authors: lofaro lr. Respir Med. 2022 Nov-Dec;204:106990. doi: 10.1016/j.rmed.2022.106990. Epub 2022 Oct 12. Respir Med. 2022. PMID: 36283245 Free article.

2

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.

Raghu G, Flaherty KR, Lederer DJ, Lynch DA, Colby TV, Myers JL, Groshong SD, Larsen BT, Chung JH, Steele MP, Benzaquen S, Calero K, Case AH, Criner GJ, Nathan SD, Rai NS, Ramaswamy M, Hagmeyer L, Davis JR, Gauhar UA, Pankratz DG, Choi Y, Huang J, Walsh PS, Neville H, Lofaro LR, Barth NM, Kennedy GC, Brown KK, Martinez FJ. Raghu G, et al. Among authors: lofaro lr. Lancet Respir Med. 2019 Jun;7(6):487-496. doi: 10.1016/S2213-2600(19)30059-1. Epub 2019 Apr 1. Lancet Respir Med. 2019. PMID: 30948346

3

An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer.

Silvestri GA, Bevill BT, Huang J, Brooks M, Choi Y, Kennedy G, Lofaro L, Chen A, Rivera MP, Tanner NT, Vachani A, Yarmus L, Pastis NJ. Silvestri GA, et al. Chest. 2020 Jun;157(6):1656-1664. doi: 10.1016/j.chest.2019.12.024. Epub 2020 Jan 21. Chest. 2020. PMID: 31978428

4

Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.

Richeldi L, Scholand MB, Lynch DA, Colby TV, Myers JL, Groshong SD, Chung JH, Benzaquen S, Nathan SD, Davis JR, Schmidt SL, Hagmeyer L, Sonetti D, Hetzel J, Criner GJ, Case AH, Ramaswamy M, Calero K, Gauhar UA, Patel NM, Lancaster L, Choi Y, Pankratz DG, Walsh PS, Lofaro LR, Huang J, Bhorade SM, Kennedy GC, Martinez FJ, Raghu G. Richeldi L, et al. Among authors: lofaro lr. Am J Respir Crit Care Med. 2021 Jan 15;203(2):211-220. doi: 10.1164/rccm.202003-0877OC. Am J Respir Crit Care Med. 2021. PMID: 32721166 Clinical Trial.

5

Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.

Lee HJ, Mazzone P, Feller-Kopman D, Yarmus L, Hogarth K, Lofaro LR, Griscom B, Johnson M, Choi Y, Huang J, Bhorade S, Spira A, Kennedy GC, Wahidi MM; Percepta Registry Investigators. Lee HJ, et al. Among authors: lofaro lr. Chest. 2021 Jan;159(1):401-412. doi: 10.1016/j.chest.2020.07.067. Epub 2020 Aug 3. Chest. 2021. PMID: 32758562

6

Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.

Choi Y, Qu J, Wu S, Hao Y, Zhang J, Ning J, Yang X, Lofaro L, Pankratz DG, Babiarz J, Walsh PS, Billatos E, Lenburg ME, Kennedy GC, McAuliffe J, Huang J. Choi Y, et al. BMC Med Genomics. 2020 Oct 22;13(Suppl 10):151. doi: 10.1186/s12920-020-00782-1. BMC Med Genomics. 2020. PMID: 33087128 Free PMC article.

7

Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.

Johnson MK, Wu S, Pankratz DG, Fedorowicz G, Anderson J, Ding J, Wong M, Cao M, Babiarz J, Lofaro L, Walsh PS, Kennedy GC, Huang J. Johnson MK, et al. BMC Cancer. 2021 Apr 13;21(1):400. doi: 10.1186/s12885-021-08130-x. BMC Cancer. 2021. PMID: 33849470 Free PMC article.

8

The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.

Lasky JA, Case A, Unterman A, Kreuter M, Scholand MB, Chaudhary S, Lofaro LR, Johnson M, Huang J, Bhorade SM, Kennedy GC. Lasky JA, et al. Among authors: lofaro lr. Ann Am Thorac Soc. 2022 Jun;19(6):916-924. doi: 10.1513/AnnalsATS.202107-897OC. Ann Am Thorac Soc. 2022. PMID: 34889723 Clinical Trial.

9

Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.

Sethi S, Oh S, Chen A, Bellinger C, Lofaro L, Johnson M, Huang J, Bhorade SM, Bulman W, Kennedy GC. Sethi S, et al. BMC Pulm Med. 2022 Jan 6;22(1):26. doi: 10.1186/s12890-021-01772-4. BMC Pulm Med. 2022. PMID: 34991528 Free PMC article.

10

Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.

Mazzone P, Dotson T, Wahidi MM, Bernstein M, Lee HJ, Feller Kopman D, Yarmus L, Whitney D, Stevenson C, Qu J, Johnson M, Walsh PS, Huang J, Lofaro LR, Bhorade SM, Kennedy GC, Spira A, Rivera MP; AEGIS Study Team; Percepta Registry Investigators. Mazzone P, et al. Among authors: lofaro lr. PLoS One. 2022 Jul 13;17(7):e0268567. doi: 10.1371/journal.pone.0268567. eCollection 2022. PLoS One. 2022. PMID: 35830375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page